Conclusion: Post-exercise high fat feeding does not augment mRNA expression of genes associated with regulatory roles in mitochondrial biogenesis though it does increase lipid gene expression. However, post-exercise p70S6K1 activity is reduced under conditions of high fat feeding thus potentially impairing skeletal muscle remodelling processes.
Introduction
Traditional nutritional strategies for endurance athletes have largely focused on ensuring high CHO availability before, during and after each training session (2) . However, accumulating data from our laboratory (7, 29) exercise following "fat adaptation" protocols (10). Taken together, these data suggest carefully chosen periods of reduced CHO but concomitant high fat availability may therefore represent a strategic approach for which to maximise both training-induced skeletal muscle mitochondrial biogenesis and the enhanced capacity to utilise lipid sources as fuels during exercise.
However, such a feeding strategy is not without potential limitations especially if performed on consecutive days. Indeed, reduced CHO availability impairs acute training intensity (17, 39) and five days of high fat feeding reduces pyruvate dehydrogenase (PDH) activity (35), thus potentially leading to a de-training effect, reduced capacity to oxidise CHO and ultimately, impaired competition performance (17, 39). Moreover, although many endurance traininginduced skeletal muscle adaptations are regulated at a transcriptional level, the turnover of myofibrillar (i.e. contractile) proteins are largely regulated through the translational machinery and the mechanistic target of rapamycin complex (mTOR) and ribosomal protein S6 kinase 1 (p70S6K) signalling axis (28). In this regard, recent data suggests high circulating FFA availability impairs muscle protein synthesis despite the intake of high quality protein, albeit examined via lipid and heparin fusion and euglycemic hyperinsulemic clamp conditions (36).
With this in mind, the aim of the present study was to examine the effects of reduced CHO but high post-exercise fat availability on the activation of key cell signalling kinases and expression of genes with putative roles in the regulation of mitochondrial biogenesis, lipid metabolism and muscle protein synthesis. In accordance with the original train-low investigations (16, 17, 29, 39), we employed a twice per day exercise model whereby trained male runners completed a morning high-intensity interval training session followed by an afternoon training session consisting of steady-state running. Runners completed the exercise protocols under two different dietary conditions (both energy and protein matched) consisting of high CHO availability (HCHO) in the recovery period after both training sessions (i.e. best practice nutrition) or alternatively, reduced CHO but high fat availability in the post-exercise recovery periods (HFAT). We specifically hypothesised that our high fat feeding protocol would enhance cell signalling and the expression of those genes with putative roles in the regulation of mitochondrial biogenesis and lipid metabolism but would also impair the activity of muscle protein synthesis related signalling.
Methods

Subjects:
Ten trained male runners volunteered to participate in the study (mean ± SD: age, 24 ± 1.5 years; body mass, 75.9 ± 6 kg; height, 177.3 ± 7.2 cm; VO 2peak , 60 ± 3.6 ml·kg -1 ·min -1 ). All subjects gave written informed consent prior to participation after all experimental procedures and potential risks had been fully explained. None of the subjects had any history of musculoskeletal or neurological disease, nor were they under any pharmacological treatment over the course of the testing period. Subjects were instructed to refrain from any strenuous physical activity, alcohol and caffeine consumption in the 48h prior to each experimental trial.
The study was approved by the ethics committee of Liverpool John Moores University.
Design:
In a repeated measures, randomised, cross-over design separated by 7 days, subjects Preliminary testing: At least 7-10 days prior to the first main experimental trial, subjects performed a maximal incremental running test to volitional fatigue on a motorised treadmill (h/p/Cosmos, Nussdorf-Traunstein, Germany) in order to determine maximal oxygen uptake.
Following a 10 minute warm up at a self-selected treadmill speed the maximal incremental test commenced, beginning with a 2-min stage at a treadmill speed of 10km/h. Running speed was then increased by 2km/h every 2-min until a speed of 16km/h was reached, after which the treadmill inclined by 2% every 2-min until volitional exhaustion. VO 2peak was defined as the highest VO 2 value obtained during any 10-s period and was stated as being achieved by two of the following criteria: 1) heart rate was within 10 beats.min -1 (bpm) of age-predicted maximum,
2) respiratory exchange ratio > 1.1, and 3) plateau of oxygen consumption despite increased workload. On their second visit to the laboratory (approx. 3 days later), subjects completed a running economy test in order to determine their individual running speeds for subsequent experimental trials. Following a warm up, the test began with a 5-min stage at a treadmill speed of 8km/h with 1% incline and speed was then increased by 1km/h every 5-mins thereafter . The test was stopped when >90% of the previously determined VO 2peak was reached. These measurements were recorded via breath-by-breath gas measurements obtained continuously throughout both tests using a CPX Ultima series online gas analysis system (Medgraphics, Minnesota, US). The test-retest reliability of this system in our laboratory when quantified using 95% limits of agreement is 0.29 ± 2.4 ml.kg -1 min -1 (data were compiled from comparison of the oxygen uptake during the HIT protocols in the HCHO and HFAT trials undertaken in the present study). Heart rate (Polar, Kempele, Finland) was also recorded continuously during exercise. Figure 1 ). Following the recovery period, another venous blood sample was obtained immediately prior to commencing the afternoon SS exercise protocol. After a 5-min warm up at a self-selected treadmill speed, subjects subsequently commenced the 60-min steady state running (SS) protocol at a velocity corresponding to 70% VO 2peak . During exercise, subjects also consumed 60 g.h Blood sampling and analysis: Venous blood samples were collected into vacutainers containing EDTA or lithium heparin and stored on ice until centrifugation at 1500g for 15-mins at 4ºC.
Following centrifugation, aliquots of plasma were stored in a freezer at -80ºC for subsequent analysis. Samples were later analysed for plasma glucose, lactate, non-esterified fatty acids (NEFA), glycerol, and β-hydroxybutyrate using commercially available enzymatic spectrophotometric assays (RX Daytona Analyser, Randox, Co. Antrim, UK) as per the manufacturers" instructions. the hexokinase method using a commercially available kit (GLUC-HK, Randox Laboratories, Antrim, UK). Glycogen concentration is expressed as mmol.kg -1 dry weight and intra-assay coefficients of variation were <5%.
RNA isolation and analysis:
Muscle biopsy samples (~20 mg) were homogenized in 1ml TRIzol reagent (Thermo Fisher Scientific, UK) and total RNA isolated according to manufacturer"s guidelines. Concentrations and purity of RNA were assessed by UV spectroscopy at ODs of 260
and 280 nm using a Nanodrop 3000 (Fisher, Rosklide, Denmark). 70 ng RNA was then used for each PCR reaction. Samples were ran in duplicate.
Primers:
Identification of primer sequences was enabled by Gene (NCBI, http://www.ncbi.nlm.nih.gov.gene) and primers designed using Primer-BLAST (NCBI, http://www.ncbi.nlm.nih.gov/tools/primer-blast). Specificity was ensured using sequence homology searches so the primers only matched the experimental gene with no unintended targets identified for primer sequences. In order to prevent amplification of gDNA, primers were ideally designed to yield products spanning exon-exon boundaries. 3 or more GC bases in the last 5 bases at the 3 end, and secondary structure interactions (hairpins, self-dimer and cross dimer) within the primers were avoided so there would be no non-specific amplification. All primers were between 16 and 25bp, and amplified a product between 141 -244bp. 
Results
Physiological responses and substrate utilisation during exercise.
Comparisons of subjects" heart rate, RPE and substrate oxidation during the HIT and SS protocols are displayed in Table 1 and 2, respectively. Heart rate, RPE and lipid oxidation (all P<0.01) all displayed progressive increases during both HIT (see Table 1 ) and SS exercise (see Table 2 ) whereas CHO oxidation displayed a progressive decrease (P<0.01) during both exercise protocols. In accordance with identical pre-exercise feeding in HIT, no significant differences 0.52 and 0.56, respectively). In contrast, however, during the SS exercise protocol CHO oxidation was significantly greater in HCHO compared to HFAT (P<0.001) whereas fat oxidation was significantly greater during HFAT compared to HCHO (P < 0.001).
Plasma metabolite responses: Plasma glucose, lactate, NEFA, glycerol and β-hydroxybutyrate all displayed significant changes (all P<0.01) over the sampling period (see Table 3 ). However, in accordance with the provision of post-exercise CHO feeding in the HCHO trial, plasma glucose was significantly higher compared with HFAT (P<0.01) whereas post-exercise high fat feeding in HFAT induced significantly greater plasma NEFA, glycerol and β-OHB (all P<0.01)
in HFAT compared with the HCHO trial.
Muscle glycogen and exercise induced cell signalling: Exercise induced significant decreases (P<0.01) in muscle glycogen immediately post-SS though no differences were apparent between HCHO and HFAT at this time-point (see Figure 2A) . However, in accordance with the provision of CHO after the SS exercise protocol in HCHO, muscle glycogen re-synthesis was observed such that significant differences between HCHO and HFAT (P=0.01) were observed at 3 h and 15 h post-SS exercise. Neither exercise (P =0.407) nor dietary condition (P = 0.124) affected AMPK-α2 activity at any time-point studied (see Figure 2B ). In contrast, p70S6K1 activity was significantly increased 3 h post-SS exercise (30-mins post-feeding) (P<0.01), although this increase was supressed (P=0.08) in HFAT (see Figure 2C ). Furthermore, p70S6K1 activity was significantly reduced at 15 h post-SS exercise when participants were fasted compared with pre-HIT when they were high CHO and protein fed (P<0.01).
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Copyright © 2016 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited. Figure 3A -F). In contrast, the exercise-induced increase (P=0.001) in PDK4 mRNA was greater in HFAT versus HCHO (P=0.003). Similarly, mRNA expression of CD36 (P=0.05) and CPT1 (P=0.02) was significantly greater in HFAT in recovery from the SS exercise protocol (see Figure 3) . In contrast, neither exercise (P=0.12) nor diet (P=0.31) significantly affected GLUT expression (see Figure 3 ).
Discussion
The aim of the present study was to examine the effects of reduced CHO but high post-exercise fat availability on the activation of key cell signalling kinases and expression of genes with putative roles in the regulation of mitochondrial biogenesis, lipid metabolism and muscle protein synthesis. When compared with high CHO availability, we observed that post-exercise high fat feeding had no modulatory affect on AMPK-α2 activity or the expression of those regulatory genes associated with mitochondrial biogenesis. Furthermore, although post-exercise high fat feeding augmented the expression of genes involved in lipid transport (i.e. FAT/CD36) and oxidation (i.e. CPT1), we also observed suppression of p70S6K1 activity despite sufficient postexercise protein intake. This latter finding suggests that post-exercise high fat feeding may impair the regulation of muscle protein synthesis and skeletal muscle remodelling processes, thereby potentially causing maladaptive responses for training adaptation if performed longterm.
In accordance with the original train-low investigations examining cycling or knee extensor exercise (16, 17, 29, 39), we also employed a twice per day protocol, albeit consisting of
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morning HIT and afternoon SS running exercise protocol. This model is practically relevant
given that many elite endurance athletes (including runners) train multiple times per day with limited recovery time between training sessions (14). Given that reduced CHO availability impairs high-intensity training capacity (17, 39), we also chose to schedule the HIT session in the morning period after a standardised high CHO breakfast. As expected, no differences in cardiovascular strain, ratings of perceived exertion, substrate utilisation and plasma metabolite responses were observed between the HCHO and HFAT trials during the HIT session (see Table   1 and 3). Following completion of the HIT protocol, subjects then adhered to a HCHO or HFAT feeding protocol in the 3.5 h prior to commencing the afternoon SS exercise. Given that exogenous CHO feeding during exercise reduces oxidative adaptations even in the presence of reduced pre-exercise muscle glycogen (29), we also chose to feed exogenous CHO (at a rate of 60 g/h) during the afternoon SS protocol during the HCHO trial. Although we did not directly quantify muscle glycogen immediately prior to SS exercise, plasma metabolite and substrate utilisation during SS exercise were clearly suggestive of differences in both endogenous and exogenous CHO availability between the HCHO and HFAT trials. Indeed, plasma NEFA, glycerol, β-OHB and whole body lipid oxidation were all greater during SS exercise undertaken in the HFAT trial compared with the HCHO trial (see Table 2 and 3). On the basis of comparable muscle glycogen data post-SS exercise (see Figure 2A ) and greater whole body CHO oxidation during the HCHO trial (see Table 2 ), we also suggest that exercise-induced muscle glycogen utilisation was greater during the SS exercise protocol when completed in the HCHO conditions (7).
Perhaps surprisingly, we observed that our SS exercise protocol did not increase AMPK-α2 activity in either the HCHO or HFAT trial. However, there are likely a number of
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Indeed, exercise-induced AMPK activation is known to be intensity dependent where >70% VO 2max is likely required to induce metabolic perturbations sufficient to mediate a signalling response (13). Furthermore, the AMPK response to exercise is attenuated with exercise training (8), an effect that is especially relevant for the present investigation given the trained status of our chosen population and the low plasma lactate observed (approximately 2 mmol.L -1 ) during SS exercise. Reduced absolute muscle fibre recruitment from the vastus lateralis, when compared with other lower extremity muscles recruited during walking and running (19), or when exercising at similar relative intensities during cycling (4) and where AMPK activation is typically reported (22) could also contribute, in part, to the lack of AMPK signalling observed here. Finally, although exercise-induced AMPK activity is also thought to be regulated, in part, via a glycogen binding domain on β-subunit of the AMPK heterotrimer (26), it is possible that our runners did not exceed a potential "muscle glycogen threshold" that is required to fully activate the AMPK complex during prolonged endurance exercise (30). Indeed, previous data from our laboratory also using running exercise protocols (6,7) have typically only observed AMPK related signalling when post-exercise whole muscle homogenate glycogen is <200 mmol.kg -1 dw. Despite previous suggestions that train-low training sessions should be targeted to SS exercise protocols so as to not compromise training intensity (5), our data therefore suggest (at least for AMPK mediated signalling) that perhaps it is the actual completion of a highintensity stimulus per se (especially in trained athletes) that is really required to create a metabolic milieu that is conducive to augmentation of necessary signalling networks.
In contrast to Yeo et al. (38), we also observed no modulatory effect of post-exercise high fat availability on resting AMPK-α2 activity. Indeed, these authors observed that 5 days of a fat
loading protocol increased resting AMPK-α2 activity as well as the exercise-induced phosphorylation of ACC Ser221 . Such discrepancies between studies are likely due to the differences in duration of high fat feeding in that we adopted an acute high fat feeding protocol (<24 h) whereas the latter authors adopted a 5 day "fat adaptation" protocol that also increased resting intramuscular triglyceride (IMTG) stores. In this regard, it is noteworthy that the magnitude of change in resting AMPK-α2 activity was positively correlated with the elevations in IMTG storage (38).
In contrast to our hypothesis, we also observed comparable 2-3 fold changes between trials in mRNA expression of those genes with key regulatory roles associated with mitochondrial biogenesis. For example, the expression of PGC-1α, p53, Tfam, PPAR and ERRα mRNA were all elevated with similar magnitude and time-course in recovery from the SS protocol in both the HCHO and HFAT trials. Such data conflict with previous observations from our laboratory (7) and others (32) where post-exercise CHO restriction (i.e. keeping muscle glycogen low) augments the expression of many of the aforementioned genes. However, in our previous report we simultaneously adopted a CHO but calorie restriction feeding protocol whereas the present design incorporated a reduced CHO but isocaloric and protein matched feeding protocol in our HFAT trial. Given the similarities in metabolic adaptation to both CHO and calorie restriction, such data raise the question as to whether the enhanced mitochondrial responses observed when "training low" are due to transient periods of CHO restriction, calorie restriction or indeed, a combination of both. This point is especially relevant from an applied perspective given that many endurance athletes present daily with transient periods of both CHO and calorie restriction due to multiple training sessions per day as well as longer term periods of sub-optimal energy availability (14).
In agreement with multiple studies demonstrating a role of both acute elevations in FFA availability (7, 23) as well as high fat feeding protocols (11), we also observed that post-exercise expression of PDK4, FAT/CD36 and CPT1 mRNA expression were elevated in the HFAT trial versus the HCHO trial. However, unlike Arkinstall et al. (4), we did not detect any suppressive effects of high fat availability on GLUT4 mRNA expression though a longer and more severe period of CHO restriction utilised by these investigators (i.e. 48 h of absolute CHO intake <1 g/kg body mass resulting in muscle glycogen levels <150 mmol.kg status with some studies reporting increases (25) and others, no change. When examined quantitatively using the [γ -32 P] ATP kinase assay, our data agree with previous observations from Apro et al. (3) who also reported no change but yet, conflict with recent data from our group where we observed an exercise-induced suppression of p70S6K activity (18). Nonetheless, the exhaustive (a fatiguing cycling HIT protocol) and muscle glycogen depleting (<100 mmol.kg -1 dw) nature of the latter exercise protocol versus the moderate-intensity nature of the afternoon SS running protocol studied here, likely explains the discrepancy between studies.
In relation to the effects of post-exercise feeding, we also provide novel data by demonstrating that post-exercise high fat feeding was associated with a suppression of p70S6K activity (albeit P=0.08) at 3 h post-completion of the SS exercise protocol when compared with the elevated response observed in HCHO (when using both a mean difference and standard deviation of differences of 50 fmol.min -1 .mg -1 , we estimate a sample size of 12-13 would be required to achieve statistical significance with 90% power, as calculated using Minitab statistical software, version 17). Although we did not measure circulating insulin levels in this study, it is of course possible that the suppressed p70S6K response observed here may be due to reduced upstream insulin mediated activation of protein kinase B (PKB). Indeed, we recently observed postexercise p70S6K activity to be suppressed in conditions of simultaneous carbohydrate and calorie restriction in a manner associated with reduced insulin and upstream signalling of PKB running at a workload equal to 85% VO 2peak interspersed by 1min recovery. SS = 1-hour steady state running at a workload equal to 70% VO 2peak . 
